ARCHIVES

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

This article is from The Cancer Letter archive.

Vol. 07 No. 30 | July 24, 1981

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995